Article Text

Download PDFPDF
Review: metered dose inhalers with a holding chamber do not differ from nebulisers for hospital admission rates in asthma

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Q In patients with acute asthma, is inhalation of β2 agonists from a metered dose inhaler (MDI) with a holding chamber more effective than inhalation from a nebuliser for reducing hospital admission rates or duration of inpatient stay?


Embedded ImageData sources:

Cochrane Airways Group Trials Register (November 2002), the Cochrane Library (2002, Issue 3), bibliographies of relevant articles, and individual researchers in the field.

Embedded ImageStudy selection and assessment:

randomised controlled trials (RCTs) published in any language that compared any β2 agonist given by an MDI with any holding chamber with the same β2 agonist given by any nebuliser in adults or children with acute …

View Full Text


  • For correspondence: Dr C Cates, Manor View Practice, Bushey Health Centre, Bushey, Hertfordshire, UK.

  • Sources of funding: Garfield Weston Foundation, UK and Canadian Institute on Health Research (CIHR), Ottawa, Canada.